Insider Selling: Plexus (NASDAQ:PLXS) Director Sells $71,735.00 in Stock

Plexus Corp. (NASDAQ:PLXS) Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the completion of the transaction, the director owned 7,665 shares of the company’s stock, valued at approximately $1,099,697.55. The trade was a 6.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Plexus Stock Up 2.1%

PLXS stock traded up $2.98 during midday trading on Tuesday, hitting $145.41. The stock had a trading volume of 199,835 shares, compared to its average volume of 180,507. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77. The firm has a market cap of $3.89 billion, a price-to-earnings ratio of 23.23 and a beta of 0.80. The business has a 50-day moving average of $143.33 and a two-hundred day moving average of $137.09. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $172.89.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.30. The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.85 EPS. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, equities research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of PLXS. Salomon & Ludwin LLC purchased a new stake in shares of Plexus during the third quarter valued at $30,000. Allworth Financial LP raised its position in Plexus by 70.1% in the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after buying an additional 103 shares during the last quarter. Huntington National Bank lifted its stake in Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after acquiring an additional 95 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Plexus during the 3rd quarter valued at about $72,000. Finally, CWM LLC grew its stake in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after acquiring an additional 213 shares during the period. 94.45% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

PLXS has been the subject of a number of analyst reports. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Needham & Company LLC raised their price objective on Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Stifel Nicolaus set a $150.00 price objective on Plexus in a research note on Friday, October 24th. Benchmark reissued a “buy” rating and issued a $165.00 target price on shares of Plexus in a research note on Friday, October 24th. Finally, Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Plexus has an average rating of “Hold” and a consensus price target of $159.00.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.